Skip to content
DraconiticResearch
Search Sources API
190,851 studies31 sourcesUpdated 46 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1068 Innate and adaptive immune responses and antitumor activity associated with ARV-6723, a PROTAC HPK1 degrader, in exhausted/post-immune checkpoint inhibitor (ICI) preclinical settings

4 more authors
  1. 1Arvinas Operations, Inc., New Haven, CT, USA
  2. 22Arvinas Operations, Inc., New Haven, CT, USA

Related

  1. m6A-modified mRNA–LNP system enables in vivo CAR expression and is associated with antitumor immune responses
    Sikun Meng, Tomoaki Hara, Tetsuya Sato +14
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  2. Ascorbic Acid Potentiates Cisplatin-Induced Antitumor Activity in HeLa Cervical Cancer Cells: Oxidative Stress, Mitochondrial Dysfunction, Apoptosis, and 3D Spheroid Responses
    Mehmet Emin Ayağ, Harun Egemen Tolunay, Mehmet Cudi Tuncer +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. BRCA1 Mutation-Recognizing Tetrahedral Framework Nucleic Acid Nanoplatform Enables Coordinated PARP/WEE1 Inhibition and STING-Associated Antitumor Immunity in Ovarian Cancer.
    Chenyi Wang, Mengying Yao, Jinhui Xie +5
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  4. Butyrate-associated antiproliferative and antitumor effects of Eubacterium limosum KGMB01548 in colorectal cancer
    Seung Yeob Yu, Jeong Eun Bak, Byeong Seob Oh +6
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  5. Probiotic-hydrogel systems for microbiome-associated diseases: design principles, preclinical evidence, and translational challenges.
    Yu Zhou, Guannan Zhang, Qinying Shi +3
    Journal of biological engineeringPeer-reviewedCC BY-NC-NDFull textGeneral biochemistryEurope PMCPMC
BibTeX
@article{wu20261068,
  title = {{1068 Innate and adaptive immune responses and antitumor activity associated with ARV-6723, a PROTAC HPK1 degrader, in exhausted/post-immune checkpoint inhibitor (ICI) preclinical settings}},
  author = {Wendy Wu and Rebecca Conrad and Morena Scopel and John Corradi and Kim Davenport and Gregory Cadelina and Jennifer Pizzano and Angela Cacace and Anna C Van Acker and William Corwin and Albert DeBerardinis and Christopher Kuhlberg and Eric Masson and Ignacio J Juncadella and Sean Landrette and XiaoZhe (Janet) Wang},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1068},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1068},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1068 Innate and adaptive immune responses and antitumor activity associated with ARV-6723, a PROTAC HPK1 degrader, in exhausted/post-immune checkpoint inhibitor (ICI) preclinical settings
AU  - Wendy Wu
AU  - Rebecca Conrad
AU  - Morena Scopel
AU  - John Corradi
AU  - Kim Davenport
AU  - Gregory Cadelina
AU  - Jennifer Pizzano
AU  - Angela Cacace
AU  - Anna C Van Acker
AU  - William Corwin
AU  - Albert DeBerardinis
AU  - Christopher Kuhlberg
AU  - Eric Masson
AU  - Ignacio J Juncadella
AU  - Sean Landrette
AU  - XiaoZhe (Janet) Wang
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1068
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1068
SN  - 2051-1426
ER  -